BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26282641)

  • 1. Combined-Modality Therapy for Early-Stage Diffuse Large B-Cell Lymphoma: Knowing When to Quit.
    Longo DL
    J Clin Oncol; 2015 Nov; 33(32):3684-5. PubMed ID: 26282641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is consolidative radiotherapy needed after chemotherapy in early stage diffuse large B‑cell lymphoma?].
    Nieder C
    Strahlenther Onkol; 2016 May; 192(5):354-5. PubMed ID: 27074842
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?
    Vargo JA; Gill BS; Balasubramani GK; Beriwal S
    J Clin Oncol; 2015 Nov; 33(32):3710-7. PubMed ID: 26261253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy after R-CHOP for diffuse large B-cell lymphoma: the gain remains.
    Yahalom J
    J Clin Oncol; 2010 Sep; 28(27):4105-7. PubMed ID: 20713874
    [No Abstract]   [Full Text] [Related]  

  • 5. Advanced DLBCL: as systemic therapy improves, the need for RT diminishes.
    Canellos GP
    Oncology (Williston Park); 2014 Dec; 28(12):1085-6. PubMed ID: 25510807
    [No Abstract]   [Full Text] [Related]  

  • 6. Who should-or should not-receive RT for DLBCL?
    Connors JM
    Oncology (Williston Park); 2014 Dec; 28(12):1093-4. PubMed ID: 25510808
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.
    Ballonoff A; Rusthoven KE; Schwer A; McCammon R; Kavanagh B; Bassetti M; Newman F; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1465-71. PubMed ID: 18495371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of radiotherapy in chemoradiation treatment for nodal diffuse large B-cell non-Hodgkin lymphoma].
    Vinogradova YN; Iliin NV
    Vopr Onkol; 2015; 61(1):96-101. PubMed ID: 26016153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse prognosis of bulky disease in good-risk DLBCL.
    Ribera JM
    Lancet Oncol; 2008 May; 9(5):406-7. PubMed ID: 18452849
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.
    Wu RY; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Liu QF; Wang ZY; Qi SN; Lu NN; Chen B; Zhang XM; Zhou LQ; Liu XF; Yu ZH
    Am J Clin Oncol; 2014 Feb; 37(1):41-6. PubMed ID: 22992625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapy.
    Campbell BA; Connors JM; Gascoyne RD; Morris WJ; Pickles T; Sehn LH
    Cancer; 2012 Sep; 118(17):4156-65. PubMed ID: 22252721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiotherapy to an initial bulky mass in diffuse large B-cell lymphoma: lack of survival benefit.
    Tomita N; Kodama F; Motomura S; Itoh S; Ohshima R; Hyo R; Kawano T; Hashimoto C; Takemura S; Yamazaki E; Fujita H; Fujisawa S; Ogawa K; Kanamori H; Ishigatsubo Y
    Int J Lab Hematol; 2008 Feb; 30(1):53-7. PubMed ID: 18190468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary anaplastic large B-cell lymphoma in mandible: Long-term complete remission with R-CHOP regimen and involved field radiotherapy.
    Niscola P; Palombi M; Trawinska MM; Scaramucci L; Giovannini M; Perrotti AP; Fabritiis Pd; Fratoni S
    Oral Oncol; 2009 Sep; 45(9):e113. PubMed ID: 19457710
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of diffuse large B-cell lymphoma].
    Gleissner B; Zwick C; Pfreundschuh M
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1785-94; quiz 1795-6. PubMed ID: 18767006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma--De Novo Occurrence or Transformation.
    Gajendra S; Jha B; Goel S; Sahni T; Dorwal P; Sachdev R
    Turk J Haematol; 2015 Dec; 32(4):371-2. PubMed ID: 26376833
    [No Abstract]   [Full Text] [Related]  

  • 16. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
    Phan J; Mazloom A; Medeiros LJ; Zreik TG; Wogan C; Shihadeh F; Rodriguez MA; Fayad L; Fowler N; Reed V; Horace P; Dabaja BS
    J Clin Oncol; 2010 Sep; 28(27):4170-6. PubMed ID: 20713859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional survival benefit of involved-lesion radiation therapy after R-CHOP chemotherapy in limited stage diffuse large B-cell lymphoma.
    Kwon J; Kim IH; Kim BH; Kim TM; Heo DS
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):91-8. PubMed ID: 25721091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional Support for Consolidative Radiotherapy for Diffuse Large B Cell Lymphoma in the Modern Rituximab Era.
    Khan MK; Esiashvili N; Flowers C
    Acta Haematol; 2015; 134(2):109-10. PubMed ID: 25925483
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radiation therapy of localized diffuse large B-cell lymphoma].
    Itami J
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Feb; 63(3):89-92. PubMed ID: 12692962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary mediastinal large B-cell lymphoma.
    Ergul SM; Lal A; Afri L; Frei-Lahr D
    South Med J; 2002 Sep; 95(9):1005-7. PubMed ID: 12356098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.